These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7213515)

  • 1. Enhanced drug metabolism and renal dysfunction.
    Németh I; Szeleczki T
    Br J Clin Pharmacol; 1981 Jan; 11(1):92-3. PubMed ID: 7213515
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Drug metabolism in disease.
    Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of the drug metabolism capacity of the liver.
    Park BK
    Br J Clin Pharmacol; 1982 Nov; 14(5):631-51. PubMed ID: 6128018
    [No Abstract]   [Full Text] [Related]  

  • 4. The interaction of cigarette smoking and chronic drug ingestion on human drug metabolism.
    Cooksley WG; Farrell GC; Cash GA; Powell LW
    Clin Exp Pharmacol Physiol; 1979; 6(5):527-33. PubMed ID: 498592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
    Wilson VL; Larson RE; Moldowan MJ
    Chem Biol Interact; 1982 Jun; 40(2):159-68. PubMed ID: 7083391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and nutrition (review).
    McLean AE
    Nahrung; 1976; 20(4):339-42. PubMed ID: 781541
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.
    Buchanan N; Eyberg C; Davis MD
    Am J Clin Nutr; 1979 Dec; 32(12):2439-42. PubMed ID: 506967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered drug metabolism in anaesthetists exposed to volatile anaesthetic agents.
    Harman AW; Russell WJ; Frewin DB; Priestly BG
    Anaesth Intensive Care; 1978 Aug; 6(3):210-4. PubMed ID: 717769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renal disease upon drug disposition.
    Reidenberg MM; Drayer DE
    Drug Metab Rev; 1978; 8(2):293-302. PubMed ID: 363386
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum creatinine and drug half-lives in renal failure.
    Perrier D; Gibaldi M
    JAMA; 1972 Aug; 221(8):918. PubMed ID: 5068187
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in newborns with severe jaundice of unknown etiology and due to glucose-6-phosphate dehydrogenase deficiency in Greece.
    Malaka-Zafiriu K; Koliouskas D; Kontopoulos E; Danielides B; Cassimos C
    Helv Paediatr Acta; 1981; 36(2):149-58. PubMed ID: 6114077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug oxidation rates in man: lack of correlation with serum gamma-glutamyl transpeptidase and urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol.
    Smith SE; Rawlins MD
    Eur J Clin Pharmacol; 1974; 7(1):71-5. PubMed ID: 4153008
    [No Abstract]   [Full Text] [Related]  

  • 16. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug metabolism and disposition at varying levels of protein and calories in human subjects.
    Nutr Rev; 1985 Mar; 43(3):71-2. PubMed ID: 3887240
    [No Abstract]   [Full Text] [Related]  

  • 18. Individualization of drug dosage in patients with renal disease.
    Dettli L
    Med Clin North Am; 1974 Sep; 58(5):977-85. PubMed ID: 4425338
    [No Abstract]   [Full Text] [Related]  

  • 19. Ascorbic acid and drug metabolism in cynomologus monkeys.
    Green M; Turnbull J; Sauberlich H; Omaye S
    Proc West Pharmacol Soc; 1978; 21():341-4. PubMed ID: 99749
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of fever on antipyrine metabolism in children.
    Forsyth JS; Moreland TA; Rylance GW
    Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.